In This Article:
Gary Hershorn / Getty Images
Key Takeaways
-
U.S. equities were little changed at midday with the market focused on comments from the Federal Reserve coming later today.
-
Charles River Laboratories announced a shakeup of its board and the start of a strategic review, sending shares higher.
-
Super Micro Computer warned uncertainty about the economy and new Trump administration tariffs will have negative short-term impacts on its business.
U.S. equities were little changed at midday as the market awaited the Federal Reserve's interest-rate decision coming this afternoon. The Dow Jones Industrial Average was higher, the Nasdaq was lower, and the S&P 500 was basically flat.
Charles River Laboratories (CRL) was the best-performing stock in the S&P 500 after the medical testing company shook up its board and began a strategic review of its operations following pressure for changes from activist investor Elliott Investment Management.
Shares of The Walt Disney Co. (DIS) jumped when the entertainment giant posted better-than-expected results as it added streaming subscribers and had revenue growth in all three of its business segments.
Electronic Arts (EA) also reported better-than-anticipated profit and sales on higher demand for its sports portfolio. Shares of the video game maker advanced.
Shares of Super Micro Computer (SMCI), or Supermicro, declined when the computer server manufacturer warned that economic uncertainty and tariffs would likely hurt performance.
Marvell Technology (MRVL) pointed to an uncertain macroeconomic environment as it postponed its investor day and narrowed its revenue outlook. Shares sank.
Arista Networks (ANET) shares slid after the cloud networking provider kept its full-year guidance steady because of the potential negative impact of tariffs.
Oil and gold futures dropped. The yield on the 10-year Treasury note was slightly lower. The U.S. dollar gained on the euro, pound, and yen. Prices for most major cryptocurrencies advanced.
TradingView
Read the original article on Investopedia